• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 9, 2009

View Archived Issues

Reduced fractures with denosumab in postmenopausal women and men with prostate cancer

Read More

Studies with HC-056456 reveal CatSper channels as a target for blocking fertility

Read More

rAAV1-AAT gene therapy shows promise for future development in phase I trial

Read More

Doxorubicin derivative INNO-206 more potent than free doxorubicin in vivo

Read More

Merck & Co. to assess safety/efficacy of MK-2578 in kidney disease patients in phase II trial

Read More

Safety and efficacy of JTT-130 to be evaluated in obese type 2 diabetic patients

Read More

Bayer relegates clinical trials for alemtuzumab to Genzyme Japan

Read More

Bevacizumab plus erlotinib therapy shows activity in phase II clinical trial in HCC

Read More

Can-Fite BioPharma reports results from its phase II CF-101 trial in psoriasis

Read More

Opexa Therapeutics reports additional data with Tovaxin for multiple sclerosis

Read More

Novel PARP inhibitors presented by AstraZeneca for cancer therapy

Read More

R-Tech Ueno presents VAP-1 inhibitors for macular edema and other eye conditions

Read More

Akela undergoes corporate restructuring

Read More

PPARgamma agonists for the treatment of AD described by GlaxoSmithKline

Read More

Panacea Biotec discloses DPP-IV inhibitors for the treatment of type 2 diabetes

Read More

NeuroSearch patents novel dopamine and serotonin receptor ligands as antipsychotics

Read More

Luminex receives 510(k) clearance for new cystic fibrosis test

Read More

XenoPort reports results from a safety and tolerability trial of arbaclofen

Read More

LigoCyte initiates phase I/II study of nasally delivered dry powder norovirus vaccine

Read More

Shire provides update on velaglucerase alfa for Gaucher's disease

Read More

GlycoMimetics begins pilot study of GMI-1070 in sickle cell patients

Read More

Dor BioPharma receives NIH grant to support phase I/II DOR-201 trial in radiation enteritis

Read More

Evotec commences phase I trial of EVT-103

Read More

Ark Therapeutics receives feedback from MHRA on EG-013

Read More

Bayer Schering submits IND for phase I MN-IC trial, triggering milestone payments

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe